Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets
Eunice Dotse, King Hoo Lim, Meijun Wang, et al.
Life (2022) Vol. 12, Iss. 2, pp. 323-323
Open Access | Times Cited: 11

Showing 11 citing articles:

Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises
Sara Bandini, Paola Ulivi, Tania Rossi
Cells (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 5
Circulating Tumour Cells in the Prediction of Bone Metastasis
S. W. Choi, K. Sun, Jason Pui Yin Cheung, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 252-252
Open Access | Times Cited: 4
Intersecting Pathways: The Role of Hybrid E/M Cells and Circulating Tumor Cells in Cancer Metastasis and Drug Resistance
Amirali Hariri, Mina Mirian, Arezoo Khosravi, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101119-101119
Closed Access | Times Cited: 2
Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy
Αreti Strati, Panagiota Economopoulou, Evi Lianidou, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1768-1768
Open Access | Times Cited: 5
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors
Valentina Magri, Gianluigi De Renzi, Luca Marino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3752-3752
Open Access | Times Cited: 1
Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy
Yun Yang, Seewoo Kim, Sang‐Nam Lee, et al.
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy
Αreti Strati, Panagiota Economopoulou, Evi Lianidou, et al.
(2023)
Open Access | Times Cited: 3
Orthotopic model for the analysis of melanoma circulating tumor cells
Markéta Pícková, Zuzana Kahounová, Tomasz Radaszkiewicz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Liquid biopsy: paving a new avenue for cancer research
Keerthi Kurma, Zahra Eslami‐S, Catherine Alix‐Panabières, et al.
Cell Adhesion & Migration (2024) Vol. 18, Iss. 1, pp. 1-26
Open Access
A Revolutionary Era in Advancing Precision Immuno-oncology; Role of Circulating Tumor Cells
Nazila Bahmaie, Özen Özensoy Güler, Ender Şi̇mşek
The Journal of Liquid Biopsy (2024) Vol. 6, pp. 100169-100169
Closed Access
Circulating tumor cells and host immunity: A tricky liaison
Elena Muraro, Giulia Brisotto
International review of cell and molecular biology (2023), pp. 131-157
Closed Access
Page 1

Scroll to top